The Impact of Climate Change on the Prevalence of Mental Illness Symptoms

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Dr. Emanuela Taioli's work was supported by the the Center for Disease Control and Prevention (CDC) (Grant number U01-TP000573-01). Dr. Taioli's dataset was used for data analysis in this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The DUHS IRB has determined that the following protocol meets the criteria for a declaration of exemption from further IRB review as described in 45 CFR 46.101(b), 45 CFR 46.102 (f), or 45 CFR 46.102 (d), satisfies the Privacy Rule as described in 45 CFR 164.512(i), and satisfies Food and Drug Administration regulations as described in 21 CFR 56.104, where applicable. Protocol ID: Pro00105402 Reference ID: Pro00105402-INIT-1.0 Protocol Title: The potential impact of rising sea levels and storm surge on mental health in Miami, FL Principal Investigator: Rajendra Morey Review Date: April 28, 2020 Expiration Date: *Does not expire Exempt Category: Category 4: Secondary research for which consent is not required: Secondary research uses of identifiable private information or identifiable biospecimens, if at least one of the following criteria is met: i. The identifiable private information or identifiable biospecimens are publicly available; ii. Information, which may include information about biospecimens, is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be ascertained directly or through identifiers linked to the subjects, the investigator does not contact the subjects, and the investigator will not re-identify subjects; iii. The research involves only information collection and analysis involving the investigator's use of identifiable health information when that use is regulated under 45 CFR parts 160 and 164, subparts A and E [HIPAA], for the purposes of "health care operations" or "research" as those terms are defined at 45 CFR 164.501 or for "public health activities and purposes" as described under 45 CFR 164.512(b); or iv. The research is conducted by, or on behalf of, a Federal department or agency using government-generated or government-collected information obtained for nonresearch activities, if the research generates identifiable private information that is or will be maintained on information technology that is subject to and in compliance with section 208(b) of the E-Government Act of 2002, 44 U.S.C. 3501 note, if all of the identifiable private information collected, used, or generated as part of the activity will be maintained in systems of records subject to the Privacy Act of 1974, 5 U.S.C. 552a, and, if applicable, the information used in the research was collected subject to the Paperwork Reduction Act of 1995, 44 U.S.C. 3501 et seq. *This Declaration of Exemption from further IRB Review is in effect from April 28, 2020 and does not expire. However, changes to the proposed research will require an amendment requesting re-review for exemption. Reportable serious adverse events and unanticipated problems related to the research that place subjects or others at risk of physical, psychological, economic, or social harm must be promptly reported to the IRB and will result in reconsideration of the activity's exempt status.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes